ELIXCYTE

BIOLOGICAL2 trials

Sponsors

UnicoCell Biomed CO. LTD

Conditions

Knee OsteoarthritisModerate to Severe Chronic Kidney Disease

Phase 1

Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease

CompletedNCT02933827

UnicoCell Biomed CO. LTDModerate to Severe Chronic Kidney Disease

Start: 2018-05-01End: 2023-06-21Updated: 2024-02-09

Phase 3

Efficacy and Safety of ELIXCYTE Intra-articular Injection in Subject With Knee Osteoarthritis

Active, not recruitingNCT05526001

UnicoCell Biomed CO. LTDKnee Osteoarthritis

Start: 2023-07-03End: 2026-11-30Target: 165Updated: 2025-11-21

Related Papers

Real-World Data as External Control in Assessing the Efficacy of Allogeneic Adipose-Derived Stem Cells Therapy for Advanced Chronic Kidney Disease.

2025-12-011 citations